- Lexicomp. Dihydroergotamine: Drug information. In: Post TW, ed. UpToDate. 2022. https://www.uptodate.com/contents/dihydroergotamine-drug-information. Accessed June 6, 2022.
- Silberstein SD, Kori SH. Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine. CNS Drugs. 2013;27(5):385–394. doi:10.1007/s40263-013-0061-2.
- Cook RO, Shrewsbury SB, Ramadan NM. Reduced adverse event profile of orally inhaled DHE (MAP0004) vs IV DHE: potential mechanism. Headache. 2009;49(10):1423–1434. doi:10.1111/j.1526-4610.2009.01510.x.
- D.H.E. 45 (Dihydroergotamine mesylate) [package insert]. US Food and Drug Administration. Updated August 2008. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/005929s044lbl.pdf. Accessed June 6, 2022.
- Lewis PJ, Noseworthy TW, Fitzgerald AA, Andrews GC, Geeraert AJ. Rapid reversal of ergotamine-induced vasospasm. Can J Neurol Sci. 1986;13(1):72–74. doi:10.1017/s0317167100035848.
- Rahman A, Yildiz M, Dadas E, et al. Reversal of ergotamine-induced vasospasm following methylprednisolone. Clin Toxicol (Phila). 2008;46(10):1074–1076. doi:10.1080/15563650802342054.
- Schmidt R, Erasmi H, Walter M, Wolf M, Gross-Fengels W. Ergotisme et ischémie des membres [Ergotism and ischemia of the limbs]. Ann Cardiol Angeiol (Paris). 1992;41(9):489–495.
- Jeong SY, Lim ES, Shin BS, et al. Ergotism with ischemia in all four extremities: a case report. J Clin Neurol. 2006;2(4):279–282. doi:10.3988/jcn.2006.2.4.279.
- Brown AS, Hoelzer DJ, Piercy SA. Skin necrosis from extravasation of intravenous fluids in children. Plast Reconstr Surg. 1979;64(2):145–150. doi:10.1097/00006534-197908000-00002.
- Sauerland C, Engelking C, Wickham R, Corbi D. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum. 2006;33(6):1134–1141. doi:10.1188/06.ONF.1134-1141.
- Lesley WS, Lazo A, Chaloupka JC, Weigele JB. Successful treatment of cerebral vasospasm by use of transdermal nitroglycerin ointment (Nitropaste). AJNR Am J Neuroradiol. 2003;24(6):1234–1236.
- Qiu O, Chan T, Luen M, Cruz JE, Hermes-DeSantis ER. Use of nitroglycerin ointment to treat primary and secondary Raynaud’s phenomenon: a systematic literature review. Rheumatol Int. 2018;38(12):2209–2216. doi:10.1007/s00296-018-4119-9.
- Erba M, Jungreis CA, Horton JA. Nitropaste for prevention and relief of vascular spasm. AJNR Am J Neuroradiol. 1989;10(1):155–156.
- Reynolds PM, MacLaren R, Mueller SW, Fish DN, Kiser TH. Management of extravasation injuries: a focused evaluation of noncytotoxic medications. Pharmacotherapy. 2014;34(6):617–632. doi:10.1002/phar.1396.
- Hinterberger JW, Kintzi HE. Phentolamine reversal of epinephrine-induced digital vasospasm. How to save an ischemic finger. Arch Fam Med. 1994;3(2):193–195. doi:10.1001/archfami.3.2.193.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 36, 2023 - Issue 3
Case Studies
Management of a patient with unintended intravenous dihydroergotamine infusion extravasation causing brachial artery vasospasm
Jim ShengDepartment of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, TexasCorrespondence[email protected]
https://orcid.org/0000-0002-3107-2635
, MDhttps://orcid.org/0000-0002-3107-2635 & , MD